Catty....That's great. I'm very glad you're making some $ on this. I hope some other folks on the ANIP board paid attention also. When to sell? That's a tough question; since we all want to sell at the highest price possible. I fully expect this to go over $10, but depending on several events that could happen (new Emis partnerships, new Novo molecules entering Phase 1 testing, Novo making an offer to buy Emis, etc.), the share price could go much higher ($20?). I can't / won't tell you when to sell; because I don't know where the share price is going to end up, and some events could absolutely dictate the eventual share price (i.e. a Novo buyout). Also when to sell is a very individual decision based on your particular needs and tolerance for risk (meaning we don't want to see our gains evaporate). Personally, I'm hoping for $20, and if the share price approaches this price I will be very tempted. That being said, it really depends on events; because I know stocks can trade for irrationally high prices (as Emis has done in the past)
Yes I'm still in ANIP, but I'm somewhat disappointed they did not pursue Libigel, and I'm not real happy with the slow share price appreciation. I will probably hold through the end of the year to see what progress is made with development of the current drug pipeline. Regards.
News 
Market Data 
Discover 
